Market Overview:
The global ELISA POT assay kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for ELISA POT assay kits from pharmaceutical and biotechnology companies, independent research labs, and academic and research institutions across the globe. Additionally, factors such as technological advancements in ELISA POT assay kits and rising investments by key players in this market are also contributing to the growth of this market. However, stringent regulatory norms for product approvals are restraining the growth of this market to some extent.
Product Definition:
The ELISA POT assay kit is used to detect the presence of antibodies against a specific antigen in a sample. The assay is based on the principle of enzyme-linked immunosorbent assay (ELISA). The kit includes all of the reagents necessary to perform the assay, including a 96-well plate precoated with antigen.
SLC15A1 ELISA POT Assay Kits:
SLC15A1 ELISA POT assay kits are used for the detection of SLC15A1 protein in biological fluids and tissue. The SLC15A1 protein is found to be involved in the transport of amino acids, peptides, and proteins across membranes. It is also known as facilitated amino acid transmembrane transport polypeptide 1 or FLT-1 receptor.
SLC15A2 ELISA POT Assay Kits:
SLC15A2 ELISA POT assay kits are used for the detection of SLC15A2 protein in biological samples using enzyme-linked immunosorbent assay (ELISA) technique. The product is developed and manufactured by Thermo Fisher Scientific, Inc. It is a ready-to-use kit that contains everything required for performing an ELISA test, which includes standards & controls, sample preparation solutions and reagents along with the antibody of your choice.
Application Insights:
The independent research labs segment dominated the global market in 2017. This is attributed to factors such as growing demand for innovative diagnostic solutions and rising prevalence of chronic diseases. For instance, according to the CDC, around 300 million people suffer from diabetes globally which means that this disease affects nearly 9% of population in North America and Europe. Moreover, about 2 million people are diagnosed with type 1 diabetes every year worldwide while another 5-6 million individuals are estimated to be at high risk of developing this condition due to family history or obesity & related disorders. Therefore, an increasing number of patients suffering from chronic diseases across the globe is expected to contribute towards segment growth during the forecast period.
On other hand, pharmaceutical & biotech companies use ELISA POT assay kits for drug discovery and development processes mainly at early phases where target identification is required but not sufficient for clinical trials purposes (phase I).
Regional Analysis:
North America dominated the global market in 2017. This is attributed to the presence of a large number of players, increasing focus on drug discovery and development, and availability of sophisticated infrastructure for R&D. The U.S., which accounted for the largest revenue share in North America, is also one of the major markets globally owing to its strong economy and well-developed healthcare sector.
Asia Pacific region is expected to witness lucrative growth over the forecast period due to factors such as growing economy coupled with rising disposable income levels leading towards improved health outcomes; constantly improving healthcare infrastructure; increase in government spending on pharmaceuticals; and high demand from local manufacturers for quality control testing services pertaining to their products/machines are some other drivers anticipated by industry experts to propel regional growth over next eight years at a CAGR exceeding 6%.
Growth Factors:
- Increasing demand for ELISA POT Assay Kits in the life science research sector as a result of the growing popularity of protein-based assays over traditional biochemical assays.
- The increasing use of ELISA POT Assay Kits in drug discovery and development processes to identify new drug targets and biomarkers.
- Growing demand for high-throughput screening platforms that employ ELISA POT Assay Kits to enable rapid and accurate analysis of large numbers of samples simultaneously.
- The increasing use of ELISA POT Assay Kits in clinical diagnostics to detect early signs of disease, monitor patient progress, and evaluate the effectiveness of treatment regimes.
Scope Of The Report
Report Attributes
Report Details
Report Title
ELISA POT Assay Kits Market Research Report
By Type
SLC15A1 ELISA POT Assay Kits, SLC15A2 ELISA POT Assay Kits, SLC15A4 ELISA POT Assay Kits, Others
By Application
Pharmaceutical & Biotech Companies, Independent Research Labs, Academic & Research Institutions
By Companies
Assaypro, LifeSpan BioSciences, Aviva Systems Biology, Biorbyt, Thermo Fisher Scientific, Sigma-Aldrich, Cell Signaling Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global ELISA POT Assay Kits Market Report Segments:
The global ELISA POT Assay Kits market is segmented on the basis of:
Types
SLC15A1 ELISA POT Assay Kits, SLC15A2 ELISA POT Assay Kits, SLC15A4 ELISA POT Assay Kits, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical & Biotech Companies, Independent Research Labs, Academic & Research Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Assaypro
- LifeSpan BioSciences
- Aviva Systems Biology
- Biorbyt
- Thermo Fisher Scientific
- Sigma-Aldrich
- Cell Signaling Technology
Highlights of The ELISA POT Assay Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- SLC15A1 ELISA POT Assay Kits
- SLC15A2 ELISA POT Assay Kits
- SLC15A4 ELISA POT Assay Kits
- Others
- By Application:
- Pharmaceutical & Biotech Companies
- Independent Research Labs
- Academic & Research Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the ELISA POT Assay Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
ELISA POT assay kits are a type of laboratory test that is used to detect the presence of a specific protein in serum, plasma, or other biological fluid samples. ELISA POT assay kits use an antibody-antigen reaction to identify and quantify the target protein.
Some of the key players operating in the elisa pot assay kits market are Assaypro, LifeSpan BioSciences, Aviva Systems Biology, Biorbyt, Thermo Fisher Scientific, Sigma-Aldrich, Cell Signaling Technology.
The elisa pot assay kits market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 ELISA POT Assay Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 ELISA POT Assay Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 ELISA POT Assay Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the ELISA POT Assay Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global ELISA POT Assay Kits Market Size & Forecast, 2020-2028
4.5.1 ELISA POT Assay Kits Market Size and Y-o-Y Growth
4.5.2 ELISA POT Assay Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 SLC15A1 ELISA POT Assay Kits
5.2.2 SLC15A2 ELISA POT Assay Kits
5.2.3 SLC15A4 ELISA POT Assay Kits
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical & Biotech Companies
6.2.2 Independent Research Labs
6.2.3 Academic & Research Institutions
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global ELISA POT Assay Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 ELISA POT Assay Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 SLC15A1 ELISA POT Assay Kits
9.6.2 SLC15A2 ELISA POT Assay Kits
9.6.3 SLC15A4 ELISA POT Assay Kits
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical & Biotech Companies
9.10.2 Independent Research Labs
9.10.3 Academic & Research Institutions
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 SLC15A1 ELISA POT Assay Kits
10.6.2 SLC15A2 ELISA POT Assay Kits
10.6.3 SLC15A4 ELISA POT Assay Kits
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical & Biotech Companies
10.10.2 Independent Research Labs
10.10.3 Academic & Research Institutions
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 SLC15A1 ELISA POT Assay Kits
11.6.2 SLC15A2 ELISA POT Assay Kits
11.6.3 SLC15A4 ELISA POT Assay Kits
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical & Biotech Companies
11.10.2 Independent Research Labs
11.10.3 Academic & Research Institutions
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 SLC15A1 ELISA POT Assay Kits
12.6.2 SLC15A2 ELISA POT Assay Kits
12.6.3 SLC15A4 ELISA POT Assay Kits
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical & Biotech Companies
12.10.2 Independent Research Labs
12.10.3 Academic & Research Institutions
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 SLC15A1 ELISA POT Assay Kits
13.6.2 SLC15A2 ELISA POT Assay Kits
13.6.3 SLC15A4 ELISA POT Assay Kits
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical & Biotech Companies
13.10.2 Independent Research Labs
13.10.3 Academic & Research Institutions
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 ELISA POT Assay Kits Market: Competitive Dashboard
14.2 Global ELISA POT Assay Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Assaypro
14.3.2 LifeSpan BioSciences
14.3.3 Aviva Systems Biology
14.3.4 Biorbyt
14.3.5 Thermo Fisher Scientific
14.3.6 Sigma-Aldrich
14.3.7 Cell Signaling Technology
